AIM/HYPOTHESIS: Maturation of the beta cells in the islets of Langerhans is dependent upon sequential activation of different transcription factors such as Pdx-1 and Nkx6.1. This maturation is associated with an acquired sensitivity to cytokines and may eventually lead to type 1 diabetes. The aims of this study were to characterise changes in mRNA expression during beta cell maturation as well as after interleukin-1beta (IL-1beta) exposure. METHODS: Transcriptome analyses were performed on two phenotypes characterised as a glucagon-producing pre-beta-cell phenotype (NHI-glu), which matures to an IL-1beta-sensitive insulin-producing beta cell phenotype (NHI-ins). Beta cell lines over-expressing Pdx-1 or Nkx6.1, respectively, were used for functional characterisation of acquired IL-1beta sensitivity. RESULTS: During beta cell maturation 98 fully annotated mRNAs changed expression levels. Of these, 50 were also changed after 24 h of IL-1beta exposure. In addition, 522 and 197 fully annotated mRNAs, not affected by maturation, also changed expression levels following IL-1beta exposure of the beta cell and the pre-beta-cell phenotype, respectively. Beta cell maturation was associated with an increased expression of Nkx6.1, whereas both Pdx-1 and Nkx6.1 expression were decreased following IL-1beta exposure. Over-expression of Nkx6.1 or Pdx-1 in cell lines resulted in a significantly increased sensitivity to IL-1beta. CONCLUSIONS/ INTERPRETATION: These results suggest that the final beta cell maturation accompanied by increased IL-1beta sensitivity is, in part, dependent upon the expression of genes regulated by Pdx-1 and Nkx6.1. Future classification of the genes regulated by these transcription factors and changed during beta cell maturation should elucidate their role in the acquired sensitivity to IL-1beta and may be helpful in identifying new targets for intervention/prevention strategies.
AIM/HYPOTHESIS: Maturation of the beta cells in the islets of Langerhans is dependent upon sequential activation of different transcription factors such as Pdx-1 and Nkx6.1. This maturation is associated with an acquired sensitivity to cytokines and may eventually lead to type 1 diabetes. The aims of this study were to characterise changes in mRNA expression during beta cell maturation as well as after interleukin-1beta (IL-1beta) exposure. METHODS: Transcriptome analyses were performed on two phenotypes characterised as a glucagon-producing pre-beta-cell phenotype (NHI-glu), which matures to an IL-1beta-sensitive insulin-producing beta cell phenotype (NHI-ins). Beta cell lines over-expressing Pdx-1 or Nkx6.1, respectively, were used for functional characterisation of acquired IL-1beta sensitivity. RESULTS: During beta cell maturation 98 fully annotated mRNAs changed expression levels. Of these, 50 were also changed after 24 h of IL-1beta exposure. In addition, 522 and 197 fully annotated mRNAs, not affected by maturation, also changed expression levels following IL-1beta exposure of the beta cell and the pre-beta-cell phenotype, respectively. Beta cell maturation was associated with an increased expression of Nkx6.1, whereas both Pdx-1 and Nkx6.1 expression were decreased following IL-1beta exposure. Over-expression of Nkx6.1 or Pdx-1 in cell lines resulted in a significantly increased sensitivity to IL-1beta. CONCLUSIONS/ INTERPRETATION: These results suggest that the final beta cell maturation accompanied by increased IL-1beta sensitivity is, in part, dependent upon the expression of genes regulated by Pdx-1 and Nkx6.1. Future classification of the genes regulated by these transcription factors and changed during beta cell maturation should elucidate their role in the acquired sensitivity to IL-1beta and may be helpful in identifying new targets for intervention/prevention strategies.
Authors: D Ross Laybutt; Mariela Glandt; Gang Xu; Yu Bai Ahn; Nitin Trivedi; Susan Bonner-Weir; Gordon C Weir Journal: J Biol Chem Date: 2002-11-15 Impact factor: 5.157
Authors: P M Larsen; S J Fey; M R Larsen; A Nawrocki; H U Andersen; H Kähler; C Heilmann; M C Voss; P Roepstorff; F Pociot; A E Karlsen; J Nerup Journal: Diabetes Date: 2001-05 Impact factor: 9.461
Authors: P Serup; H V Petersen; E E Pedersen; H Edlund; J Leonard; J S Petersen; L I Larsson; O D Madsen Journal: Biochem J Date: 1995-09-15 Impact factor: 3.857
Authors: M Sander; L Sussel; J Conners; D Scheel; J Kalamaras; F Dela Cruz; V Schwitzgebel; A Hayes-Jordan; M German Journal: Development Date: 2000-12 Impact factor: 6.868
Authors: M F Offield; T L Jetton; P A Labosky; M Ray; R W Stein; M A Magnuson; B L Hogan; C V Wright Journal: Development Date: 1996-03 Impact factor: 6.868
Authors: A M Wägner; P Cloos; R Bergholdt; P Boissy; T L Andersen; D B Henriksen; C Christiansen; S Christgau; F Pociot; J Nerup Journal: Diabetologia Date: 2007-01-10 Impact factor: 10.122
Authors: B Reusens; T Sparre; L Kalbe; T Bouckenooghe; N Theys; M Kruhøffer; T F Orntoft; J Nerup; C Remacle Journal: Diabetologia Date: 2008-03-03 Impact factor: 10.122
Authors: Tiziana Sanavia; Chen Huang; Elisabetta Manduchi; Yanwen Xu; Prasanna K Dadi; Leah A Potter; David A Jacobson; Barbara Di Camillo; Mark A Magnuson; Christian J Stoeckert; Guoqiang Gu Journal: Front Cell Dev Biol Date: 2021-05-04
Authors: Claus H Bang-Berthelsen; Lykke Pedersen; Tina Fløyel; Peter H Hagedorn; Titus Gylvin; Flemming Pociot Journal: BMC Genomics Date: 2011-02-04 Impact factor: 3.969
Authors: T Galbo; I L Pedersen; T Fløyel; C H Bang-Berthelsen; P Serup; O D Madsen; J Hald Journal: Eur J Histochem Date: 2010-04-15 Impact factor: 3.188